Do you want to read an article? Please log in or register.
Genomic and Transcriptomic Tumor Heterogeneity in Bilateral Retinoblastoma
Ocular Oncology
Related content
Ocular Oncology
BCC developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with BAP1-TPDS
Genes Chromosomes Cancer.
Melzer C, Sharma A, Peters S, Aretz S, Biswas A, Holz FG, Loeffler KU, Herwig-Carl MC
doi: 10.1002/gcc.22724.
Retinal Diseases
Multi-view convolutional neural networks for automated ocular structure and tumor segmentation in retinoblastoma
Sci Rep
Strijbis VIJ, de Bloeme CM, Jansen RW, Kebiri H, Nguyen HG, de Jong MC, Moll AC, Bach-Cuadra M, de Graaf P, Steenwijk MD
doi: 10.1038/s41598-021-93905-2
Patient understanding of genetic information influences reproductive decision making in retinoblastoma
Clin Genet.
Foster A, Boyes L, Burgess L, Carless S, Bowyer V, Jenkinson H, Parulekar M, Ainsworth J, Hungerford J, Onadim Z, Sagoo M, Rosser E, Reddy MA, Cole T
doi: 10.1111/cge.13035.
Ocular Oncology
A Multicenter, International Collaborative Study for AJCC-Staging of Retinoblastoma: Metastasis-Associated Mortality
Ophthalmology.
Tomar AS, Finger PT, Gallie B, Mallipatna A, Kivelä TT, Zhang C, Zhao J, Wilson MW, Kim J, Khetan V, Ganesan S, Yarovoy A, Yarovaya V, Kotova E, Yousef YA, Nummi K, Ushakova TL, Yugay OV, Polyakov VG, Ramirez-Ortiz MA, Esparza-Aguiar E, Chantada G, Schaiquevich P, Fandino A, Yam JC, Lau WW, Lam CP, Sharwood P, Moorthy S, Long QB, Essuman VA, Renner LA, Català J, Correa-Llano G, American Joint Committee on Cancer Ophthalmic Oncology Task Force.
doi: 10.1016/j.ophtha.2020.05.050.
Conjunctivitis
Clinical Features Differentiating Benign From Malignant Conjunctival Tumors in Children
JAMA Ophthalmol.
Shields CL, Sioufi K, Alset AE, Boal NS, Casey MG, Knapp AN, Sugarman JA, Schoen MA, Gordon PS, Say EA, Shields JA
doi: 10.1001/
Blindness and Vision ImpairmentRetinal Diseases
Vision-Targeted Health-Related Quality of Life in Adult Survivors of Retinoblastoma
JAMA Ophthalmol.
Friedman DN, Chou JF, Francis JH, Sklar CA, Li Y, McCabe M, Robison LL, Kleinerman RA, Oeffinger KC, Abramson DH, Dunkel IJ, Ford JS
doi: 10.1001/
RECOMMENDED
Ocular Oncology
Eye-preserving therapies for advanced retinoblastoma: a multicenter cohort of 1678 patients in China
★ 3
Recommended by
Prof. Dr Ke Yao, Faculty Member
Ophthalmology
Zhou C, Wen X, Ding Y, Ding J, Jin M, Liu Z, Wang S, Han M, Yuan H, Xiao Y, Wu L, Wang J, Li Y, Yu J, Wen Y, Ye J, Liu R, Chen Z, Xue S, Lu W, Liao H, Cui J, Zhu D, Lu F, Tang S, Wu Y, Yangkyi T, Zhang G, Wubuli M, Guo H, Wang X, He Y, Sheng X, Wang Q, Luo Y, Fan J, Qi J, Yu Z, Tan J, Liang J, Sun X, Jin L, Yang X, Zhang J, Ji X, Zhao J, Jia R, Fan X
doi: 10.1016/j.ophtha.2021.09.002
Ocular OncologyFurther Publications
Defining High-Risk Retinoblastoma: A Multicenter Global Survey
JAMA Ophthalmol
Kaliki S, Shields CL, Cassoux N, Munier FL, Chantada G, Grossniklaus HE, Yoshikawa H, Fabian ID, Berry JL, McKenzie JD, Kimani K, Reddy MA, Parulekar M, Tanabe M, Furuta M, Grigorovski N, Chevez-Barrios P, Scanlan P, Eagle RC Jr, Rashid R, Coronado RD, Sultana S, Staffieri S, Frenkel S, Suzuki S, Ushakova TL, Ji X
doi: 10.1001/jamaophthalmol.2021.4732
COMMENTED
Role of the Complement System in Chronic Central Serous Chorioretinopathy: A Genome-Wide Association Study
JAMA Ophthalmol.
Schellevis RL, van Dijk EHC, Breukink MB, Altay L, Bakker B, Koeleman BPC, Kiemeney LA, Swinkels DW, Keunen JEE, Fauser S, Hoyng CB, den Hollander AI, Boon CJF, de Jong EK
doi: 10.1001/jamaophthalmol.